Medications & Pharmacology: What is the Classification of Antiparkinson?
•
3 min read
Parkinson's disease is primarily characterized by the loss of dopamine-producing neurons in the brain, leading to a deficiency of this vital neurotransmitter. The classification of antiparkinsonian drugs is based on how they address this imbalance by either supplementing dopamine, preventing its breakdown, or managing other neurotransmitter systems.
